Illicit and prescription drug abuse has reached epidemic proportions in our country. As a result, we are seeing many more infants being born with signs of neonatal abstinence syndrome. This presentation will address the incidence of neonatal abstinence syndrome among infants whose mothers consumed opioids and other drugs during pregnancy. Typical screening methods, assessment of the signs of withdrawal and management strategies will be discussed. The presentation will also discuss ways in which staff nurses can increase their inter-observer reliability when assessing infants for signs of neonatal abstinence. It is essential that adequate assessments be made by all who care for these infants so pharmacologic management can be instituted when needed. When the assessment of withdrawal is accurate and appropriate pharmacologic management is implemented infants will be able to better interact with their parents, tolerate their feedings and sleep for longer periods of time.
Learning Objectives:
Objective 1: Describe the incidence of NAS in the US & potential hospital costs.
Objective 2: Identify drugs associated with NAS.
Objective 3: Describe the appropriate way to assess neonates for signs of NAS.
Objective 4: Identify pharmacologic, non-pharmacologic and caregiving strategies for managing neonates with NAS.
To Continue, Please Select Your Country of Residence
Whoops! Please select your Country before clicking "Submit"
The GOLD Learning Lecture Library is a unique & convenient resource for Healthcare Professionals, Researchers, Students and other Educators looking to stay up to date on the latest evidence-based skills and practices. Country Category pricing has been determined by World Bank Economic Indicators. Proof of residency may be requested. Learn more about our Category Pricing Here.
